Branchioma with a nested/organoid morphology: molecular profiling of a distinctive potentially misleading variant and reappraisal of potential relationship to CD34-positive/Rb1-deficient tumors of the neck

. 2023 Oct ; 483 (4) : 541-548. [epub] 20230704

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid37401932
Odkazy

PubMed 37401932
PubMed Central PMC10611845
DOI 10.1007/s00428-023-03592-9
PII: 10.1007/s00428-023-03592-9
Knihovny.cz E-zdroje

Branchioma (previously called ectopic hamartomatous thymoma, branchial anlage mixed tumor, or thymic anlage tumor) is a rare lower neck lesion with an adult male predominance and an uncertain histogenesis. Except for 4 cases, all branchiomas described in the literature were benign. Recently, HRAS mutation was detected in one case, but still little is known about the molecular genetic background of this rare entity. We herein report the histological, immunohistochemical, and molecular genetic analysis of a branchioma with a nested/organoid (neuroendocrine-like) morphology in a 78-year-old man. Histology revealed classical branchioma areas merging with nested/organoid cellular component lacking conventional features of malignancy. Immunohistochemistry was positive for high-molecular-weight cytokeratins. CD34 was expressed in the spindle cell component. Moreover, the tumor cells showed near-complete loss of retinoblastoma (RB1) expression (<1% of cells positive). All neuroendocrine markers (synaptophysin, chromogranin, and INSM1) were negative. Next-generation sequencing (TSO500 Panel) revealed 5 pathogenic/likely pathogenic mutations including 1 mutation in KRAS and 2 different mutations in each of MSH6 and PTEN. FISH and DNA sequencing were negative for RB1 gene alterations. To our knowledge, this is the first report of a branchioma showing misleading nested/organoid morphology and the first report on Rb1 immunodeficiency in this entity, in addition to multiple gene mutations revealed by NGS.

Zobrazit více v PubMed

Jing H, Wang J, Wei H, et al. Ectopic hamartomatous thymoma: report of a case and review of literature Int J. Clin Exp Pathol. 2015;8:11776–11784. PubMed PMC

Smith PS, McClure J. Unusual subcutaneous mixed tumour exhibiting adipose, fibroblastic, and epithelial components. J Clin Pathol. 1982;35:1074–1077. doi: 10.1136/jcp.35.10.1074. PubMed DOI PMC

Rosai J, Limas C, Husband EM. Ectopic hamartomatous thymoma. A distinctive benign lesion of lower neck. Am J Surg Pathol. 1984;8:501–513. doi: 10.1097/00000478-198407000-00002. PubMed DOI

Sato K, Thompson LDR, Miyai K, et al. Ectopic hamartomatous thymoma: a review of the literature with report of new cases and proposal of a new name: biphenotypic branchioma. Head Neck Pathol. 2018;12:202–209. doi: 10.1007/s12105-017-0854-6. PubMed DOI PMC

Fetsch JF, Laskin WB, Michal M, et al. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor. Am J Surg Pathol. 2004;28:1360–1370. doi: 10.1097/01.pas.0000135518.27224.3f. PubMed DOI

Weissferdt A, Kalhor N, Petersson F, et al. Ectopic hamartomatous thymoma-new insights into a challenging entity: a clinicopathologic and immunohistochemical study of 9 cases. Am J Surg Pathol. 2016;40:1571–1576. doi: 10.1097/PAS.0000000000000699. PubMed DOI

WHO Classification of Tumours Editorial Board . Head and neck tumours. Lyon (France): International Agency for Research on Cancer; 2022.

Liang PI, Li CF, Sato Y, et al. Ectopic hamartomatous thymoma is distinct from lipomatous pleomorphic adenoma in lacking PLAG1 aberration. Histopathology. 2013;62:518–522. doi: 10.1111/his.12022. PubMed DOI

Weinreb I, O’Malley F, Ghazarian D. Ectopic hamartomatous thymoma: a case demonstrating skin adnexal differentiation with positivity for epithelial membrane antigen, androgen receptors, and BRST-2 by immunohistochemistry. Hum Pathol. 2007;38:1092–1095. doi: 10.1016/j.humpath.2007.01.029. PubMed DOI

Thompson LDR, Gagan J, Washington A, et al. Biphenotypic branchioma: a better name than ectopic hamartomatous thymoma for a neoplasm with HRAS mutation Head Neck Pathol. 2020;14:884–888. doi: 10.1007/s12105-020-01132-4. PubMed DOI PMC

Michal M, Rubin BP, Kazakov DV, et al. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor. Virchows Arch. 2020;477:219–230. doi: 10.1007/s00428-020-02774-z. PubMed DOI

Skalova A, Ptakova N, Santana T, et al. NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is “intraductal” correct? Am J Surg Pathol. 2019;43:1303–1313. doi: 10.1097/PAS.0000000000001301. PubMed DOI

Landrum MJ, Lee JM. Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence Nucleic Acids Res. 2018;46:D1062–D1067. doi: 10.1093/nar/gkx1153. PubMed DOI PMC

Michal M, Agaimy A, Contreras AL, et al. Dysplastic lipoma: a distinctive atypical lipomatous neoplasm with anisocytosis, focal nuclear atypia, p53 overexpression, and a lack of MDM2 gene amplification by FISH; a report of 66 cases demonstrating occasional multifocality and a rare association with retinoblastoma. Am J Surg Pathol. 2018;42:1530–1540. doi: 10.1097/PAS.0000000000001129. PubMed DOI

Fukunaga M. Ectopic hamartomatous thymoma: a case report with immunohistochemical and ultrastructural studies. APMIS. 2002;110:565–570. doi: 10.1034/j.1600-0463.2002.11007808.x. PubMed DOI

Weissferdt A, Moran CA. Spindle cell thymomas with neuroendocrine morphology: a clinicopathological and immunohistochemical study of 18 cases. Histopathology. 2014;65:111–118. doi: 10.1111/his.12376. PubMed DOI

Gleeson M, Herbert A, Richards A. Management of lateral neck masses in adults. BMJ. 2000;320:1521–1524. doi: 10.1136/bmj.320.7248.1521. PubMed DOI PMC

SD. B, N. UD (2020) Spindle cell lipoma. WHO Classification of Tumours of Soft Tissue and Bone Tumours, 5th ed. Lyon: IARC Press:29-30

Syed S, Martin AM, Haupt H, et al. Frequent detection of androgen receptors in spindle cell lipomas: an explanation for this lesion’s male predominance? Arch Pathol Lab Med. 2008;132:81–83. doi: 10.5858/2008-132-81-FDOARI. PubMed DOI

Kutzner H, Kaddu S, Kanitakis J, et al. Spindle cell-predominant trichodiscoma. In: Elder DE, Massi D, Scolyer RA, Willemze R, et al., editors. WHO Classification of Skin Tumours. 4. Lyon: IARC Press; 2018.

Michalova K, Kutzner H, Steiner P, et al. Spindle cell predominant trichodiscoma or spindle cell lipoma with adnexal induction? A study of 25 cases, revealing a subset of cases with RB1 heterozygous deletion in the spindle cell stroma. Am J Dermatopathol. 2019;41:637–643. doi: 10.1097/DAD.0000000000001358. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace